Deutsche Biotech Innovativ AG Stock price
Equities
DBI
DE000A0Z25L1
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 EUR | +2.97% | +4.00% | -86.75% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 25.39M 27.36M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net cash position 2021 | 18.92K 20.4K | Net cash position 2022 | 8.08K 8.7K | EV / Sales 2022 | - |
P/E ratio 2021 |
-371
x | P/E ratio 2022 |
-107
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
1 day | +2.97% | ||
1 week | +4.00% | ||
Current month | -74.00% | ||
1 month | -74.00% | ||
3 months | -86.75% | ||
6 months | -93.46% | ||
Current year | -86.75% |
Managers | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 08-12-31 |
Metod Miklus
COO | Chief Operating Officer | 65 | 19-10-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 08-12-31 |
Metod Miklus
COO | Chief Operating Officer | 65 | 19-10-06 |
Renke Lührs
CHM | Chairman | 64 | 11-02-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.04 | +2.97% | 16 |
24-03-27 | 1.01 | 0.00% | 214 |
24-03-26 | 1.01 | +1.00% | 214 |
24-03-25 | 1 | 0.00% | 214 |
24-03-22 | 1 | 0.00% | 396 |
End-of-day quote BOERSE DUESSELDORF, March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-86.75% | 1.04M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |